Promising Results for Dupilumab in Treatment of Moderate-to-

This new data on dupilumab demonstrates the drug’s potential usefulness in treating type 2 inflammation, a role which is central to respiratory diseases including COPD.

Related Keywords

Milan , Lombardia , Italy , Suryap Bhatt , European Respiratory Society , International Congress , Critical Care , Accessed September , Copd , Pulmonary , Pulmonology , Dupilumab , Inflammation ,